This was also demonstrated with Cox regression analysis, which compared the presence of ESR1 mutations with clinical characteristics such as age, previous neoadjuvant or adjuvant therapies, ER or PR expression, and mitotic index (Ki67) in primary cancer. Here, ESR1 is linked to cancer.